During the past decade, Psychoneuroendocrine Research Program conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Psychoneuroendocrine Research Program" #1 collaborator was "Stanley Medical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Psychoneuroendocrine Research Program" are "Bipolar Disorder" (2 trials), "Bipolar I Disorder" (2 trials), "Alcohol Dependence" (1 trials), "Amphetamine Abuse" (1 trials) and "Amphetamine Dependence" (1 trials). Many other conditions were trialed in "Psychoneuroendocrine Research Program" in a lesser frequency.

Most popular intervention types in "Psychoneuroendocrine Research Program" are "Drug" (4 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lurasidone" (2 trials), "Citicoline" (1 trials), "Probio-Tec BG-VCap-6.5" (1 trials) and "Quetiapine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Psychoneuroendocrine Research Program" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Psychoneuroendocrine Research Program". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Psychoneuroendocrine Research Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Psychoneuroendocrine Research Program, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".